Resistance to infection is critically dependent on the ability of pattern recognition receptors to recognize microbial invasion and induce protective immune responses. One such family of receptors are the C-type lectins, which are central to antifungal immunity 1 . These receptors activate key effector mechanisms upon recognition of conserved fungal cell-wall carbohydrates. However, several other immunologically active fungal ligands have been described; these include melanin 2,3 , for which the mechanism of recognition is hitherto undefined. Here we identify a C-type lectin receptor, melanin-sensing C-type lectin receptor (MelLec), that has an essential role in antifungal immunity through recognition of the naphthalene-diol unit of 1,8-dihydroxynaphthalene (DHN)-melanin. MelLec recognizes melanin in conidial spores of Aspergillus fumigatus as well as in other DHN-melanized fungi. MelLec is ubiquitously expressed by CD31 + endothelial cells in mice, and is also expressed by a sub-population of these cells that co-express epithelial cell adhesion molecule and are detected only in the lung and the liver. In mouse models, MelLec was required for protection against disseminated infection with A. fumigatus. In humans, MelLec is also expressed by myeloid cells, and we identified a single nucleotide polymorphism of this receptor that negatively affected myeloid inflammatory responses and significantly increased the susceptibility of stem-cell transplant recipients to disseminated Aspergillus infections. MelLec therefore recognizes an immunologically active component commonly found on fungi and has an essential role in protective antifungal immunity in both mice and humans.
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DHN-melanin biosynthetic pathway 2,9 ( Fig. 2b and Extended Data Fig. 3a ). We also confirmed loss of the MelLec ligand on ΔrodAΔpksP double mutant conidia 10 -which lack both melanin and the hydrophobin layer-using flow cytometry, immunofluorescence microscopy and our MelLec reporter cells (Extended Data Figs 1f and 3b, c). Loss of pksP did not affect conidial recognition by Fc-Dectin-1 (Extended Data Fig. 3c, d ). Moreover, we demonstrated a direct interaction of MelLec with A. fumigatus melanin ghosts (Extended Data Fig. 3e ). MelLec recognized specifically DHN-melanin, as this receptor did not detect melanin synthesized by other pathways, such as those used by Cryptococcus neoformans, and mammalian B16 melanoma cells 11 (Extended Data Fig. 3f ). In addition to A. fumigatus, we showed that MelLec recognized other pigmented fungi that produce DHN-melanin, including F. pedrosoi and C. cladosporioides 12 (Fig. 1b and Extended Data Fig. 1e ).
Although its tertiary structure is unresolved 11 , the biosynthetic pathway of DHN-melanin is well characterized in A. fumigatus 3 . To determine at which stage MelLec ligand(s) are synthesized in the pathway, we screened mutants of A. fumigatus that were deficient in the enzymes required to catalyse each step, using Fc-MelLec and immuno fluorescence microscopy, or ELISA. We confirmed that MelLec recognition was lost in ΔpksP conidia; however, MelLec recognition was unaffected in mutants deficient in the enzymes required for all other stages of the DHN-melanin biosynthetic pathway ( Fig. 2c and Extended Data Fig. 4a ). Using a pre-adsorption assay, we showed that the recognition of wild-type conidia could be inhibited by pretreating Fc-MelLec with Δayg1 ghosts (defective in the second biosynthetic step, in which MelLec ligands are still present), but not ghosts of ΔpksP (the first biosynthetic step, which lacks MelLec ligands; Extended Data Fig. 4b ). We purified YWA1 from Δayg1 conidia 13 and demonstrated that pretreatment with this compound inhibited the ability of Fc-MelLec, but not the ability of Fc-Dectin-1, to detect ΔrodA conidia or sodium hydroxide-treated wild-type conidia (Extended Data Fig. 4c, d) . Moreover, using ELISA, we demonstrated a direct interaction of MelLec with purified YWA1 (Fig. 2d ). This suggested that the ability of MelLec to recognize YWA1, as well as all of the other melanin biosynthetic intermediates (Fig. 2c) , was due to recognition of the conserved naphthalene-diol unit, present in each of the intermediates. Indeed, we revealed a direct interaction of MelLec with 1,8-dihydronaphthalene (1, , another upstream intermediate of the melanin biosynthetic pathway, by ELISA (Extended Data Fig. 4e ). The structural isomers 1,2-DHN and 1,4-DHN, which contain the naphthalene-diol unit but are not melanin intermediates, were also recognized by MelLec (Extended Data Fig. 4f ). This suggests that the position of at least one of the hydroxyls (on carbon 2, 4 or 8) on the naphthalene-diol unit is not important for recognition by MelLec. By contrast, naphthalene and 1-naphthol were not recognized by MelLec (Extended Data Fig. 4g ), indicating that the ligand of MelLec is a naphthalene-diol.
CLRs involved in fungal recognition are predominantly expressed by myeloid cells and are detectable in most tissues 1 . Using reverse transcription PCR (RT-PCR), we found that MelLec was widely expressed in mice, with the highest levels of transcript detected in the lung (Extended Data Fig. 5a ). To explore expression at a cellular level, 
we generated monoclonal antibodies by immunizing rats with murine Fc-MelLec and then screening ELISA-positive hybridoma supernatants using flow cytometry on NIH3T3 cells transfected to express full-length haemagglutinin-tagged murine MelLec. In these transfected cells, we found that MelLec was expressed as a glycosylated monomer at the cell surface, which demonstrated that this CLR did not require an adaptor for surface expression 1, 14 (Extended Data Fig. 5b , c). Although MelLec is able to sense melanin ( Fig. 2 and Extended Data Fig. 1f ), the expression of this receptor on these transfected NIH3T3 cells did not confer the ability to capture A. fumigatus conidia to the cell surface (Extended Data Fig. 5d ).
Two monoclonal antibodies (18E4 and 14C8) specific for MelLec were chosen for further characterization of receptor expression on mouse cells and tissues (Extended Data Fig. 5e ). Surprisingly, MelLec was not expressed by any examined mouse myeloid cell population (either ex vivo or in vitro bone marrow-derived), even after microbial stimulation, nor was this receptor expressed by cells in peripheral blood, bone marrow, lymphoid tissues or on platelets 15 (Extended Data Fig. 6a -c). Given the abundance of transcript, next we examined disaggregated lung tissue by flow cytometry, which revealed a distinct population of cells that expressed MelLec (Fig. 3a ). Histological visualization of MelLec expression by immunofluorescence microscopy revealed broad punctate expression of this receptor throughout the lung tissue ( Fig. 3b and Extended Data Fig. 7m ). A similar punctate staining pattern was also observed in the MelLec-expressing transfected NIH3T3 fibroblasts (Extended Data Fig. 7a ). Flow cytometry analysis showed that MelLec expression was restricted to non-haematopoietic (CD45 − ) cells ( Fig. 3c and Extended Data Fig. 7b ). Further characterization of these cells revealed that MelLec was expressed by CD31 + EpCAM − endothelial cells (EpCAM, epithelial cell adhesion molecule) ( Fig. 3d ). Expression of MelLec was also detected on CD31 + endothelial cells in all other tissues tested, including the liver, heart, kidney and small intestine (Extended Data Fig. 7c-f ). However, we also detected a unique population of CD31 + cells that co-expressed EpCAM + , but only in the lung and the liver, and these cells also expressed MelLec ( Fig. 3d and Extended Data Fig. 7c ). MelLec was not expressed on EpCAM + cells in other tissues, including in the epidermis (Extended Data Fig. 7g -j).
To gain insight into the physiological functions of MelLec, we generated mice deficient in this receptor using a conventional gene-targeting vector (Extended Data Fig. 7k , l). Exons 1-5 of the gene encoding MelLec (Clec1a) were deleted; these exons correspond to the cytoplasmic tail, transmembrane, stalk and part of the CRD region. Flow cytometry of disaggregated lung tissue, and immunofluorescence microscopy of whole lung, confirmed the lack of MelLec expression in cells from knockout mice ( Fig. 3b and Extended Data Fig. 7m , n). The MelLec-knockout mice were viable, had no gross abnormalities and had normal peripheral leucocyte counts (Supplementary Table 2 ). Intratracheal (i.t.) challenge of immunocompetent MelLec-knockout mice with wild type A. fumigatus conidia revealed no alterations in survival or in other physiological parameters, including weight (Extended Data Fig. 8a ). However, a significantly reduced influx of neutrophils into the lungs of MelLec-knockout mice could be detected shortly (4 h) after i.t. challenge (Extended Data Fig. 8b-d ), before the conidia had germinated 16 . This alteration in cellular recruitment in the MelLec-knockout mice was associated with alterations in selected Letter reSeArCH neutrophil-related cytokines, including KC (CXCL1) and granulocyte macrophage colony-stimulating factor (Extended Data Fig. 8e ). A similar alteration in neutrophil recruitment was also observed in the MelLec-knockout mice after i.t. challenge with melanin ghosts of A. fumigatus (Extended Data Fig. 8f ). There were no alterations in other pulmonary myeloid populations after conidial challenge, and by 24 h after the challenge the difference in neutrophil influx was no longer apparent (Extended Data Fig. 8g , h). There was also no change in the expression of MelLec during infection with A. fumigatus (Extended Data Fig. 8i ). Notably, the defect in early neutrophil-recruitment in the MelLec-knockout mice was lost upon i.t. challenge with ΔpksP conidia, which lack melanin (Extended Data Fig. 8j , k).
We next examined the role of MelLec during infections in corticosteroid-treated mice, to model the effects of immunosuppression 17 . Under these conditions, loss of MelLec did not significantly alter the susceptibility to infection (Extended Data Fig. 9a ). However, when we intravenously (i.v.) infected immunocompetent MelLec-knockout mice with A. fumigatus conidia 17 , we observed substantially increased susceptibility in these mice compared to the wild type ( Fig. 4a ). This increased susceptibility was associated with increased fungal burdens in several tissues, including the brain ( Fig. 4b and Extended Data Fig. 9b-d) , as well as alterations in inflammatory responses ( Fig. 4c ). IL-17 responses were unaffected 18 . Consistent with a role in melanin recognition, there was no difference in susceptibility or fungal burden between wild-type and MelLec-knockout mice after systemic infection with ΔpksP conidia ( Fig. 4d and Extended Data Fig. 9e ).
Our mouse data suggested that MelLec has a key role in the immunity to disseminated infections with Aspergillus. Therefore, we next explored the role of this receptor in humans. MelLec has been previously detected in humans on endothelial cells 19, 20 but also on myeloid cells 5,18-20 , and we found that a human MelLec Fc fusion protein (Fc-hMelLec) recognizes DHN-melanized conidia (Extended Data Fig. 10a ). A common missense single nucleotide polymorphism (SNP) within the coding region of CLEC1A (rs2306894, global minor allele frequency = 0.3295) results in an amino acid change (Gly26Ala) in the cytoplasmic tail of human MelLec. Notably, we found a highly significant association between this SNP and the risk of aspergillosis in stem-cell transplant recipients ( Fig. 4e ). This increased risk occurred when the variant was carried by the donor, but not when it was carried by the recipient. This suggests that, in humans, the protective functions of MelLec are primarily mediated by myeloid cells. In our mouse model, there was no difference in resistance to infection upon adoptive transfer of MelLec-deficient bone marrow into irradiated wild-type recipients (Extended Data Fig. 10b ).
To demonstrate the effect of the SNP in CLEC1A and subsequent amino acid substitution in MelLec on the function of myeloid cells, we analysed the responses of monocyte-derived macrophages isolated from healthy genotyped donors. We found that macrophages from the individuals carrying this SNP produced significantly less IL-1β and IL-8 after in vitro stimulation with A. fumigatus conidia compared to controls ( Fig. 4f ), whereas there was no difference in response upon stimulation with lipopolysaccharide (Extended Data Fig. 10c ). We veri fied Pooled data from two independent experiments, analysed by log-rank test. e, Cumulative incidence analysis of invasive aspergillosis after transplantation according to donor (wild-type, n = 238 individuals; SNP allele, n = 72 individuals) or recipient (wild-type, n = 228 individuals; SNP allele, n = 80 individuals) CLEC1A rs2306894 genotypes, analysed by two-sided Gray's test. f, Cytokine production in monocyte-derived macrophages, after stimulation with A. fumigatus conidia (wild-type, n = 14 individuals; SNP allele, n = 5 individuals). Values shown are mean ± s.d., analysed by two-sided Mann-Whitney U test. *P ≤ 0.05; NS, not significant; HR, hazard ratio.
Letter reSeArCH the inflammatory defect caused by this SNP in peripheral blood mononuclear cells isolated from an independent cohort (Extended Data Fig. 10d ). Moreover, using transduced RAW264.7 macrophages, we demonstrated directly that this SNP results in an inflammatory defect upon stimulation with melanin-containing conidia (Extended Data Fig. 10e ).
Melanin is considered a fungal virulence factor, providing protection against reactive oxygen species and inhibiting host-cell phagocytosis, cytokine production and apoptosis 3,10,21 . Here we show that fungal DHN-melanin is also sensed by the host, through a melanin-sensing C-type lectin receptor (MelLec) that has a crucial role in the control of systemic A. fumigatus infection in both mice and humans. However, the data presented here, as well as early studies in rats 18, 22 , show that the cellular expression of this receptor differs between species. Critically, we define a polymorphism of this receptor that, when present in donor cells, increases the susceptibility of stem-cell transplant recipients to disseminated aspergillosis. Our data therefore suggest that identifying donors carrying this SNP could help considerably to reduce the incidence of this disease in transplant recipients. It is likely that MelLec will have an important role in immunity to other melanized fungi and black yeasts 23 , especially those that cause phaeohyphomycosis, mycetoma and chromoblastomycosis.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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Mice and fungal strains. C57BL/6 and Clec1a −/− mice (8-12 weeks old) were obtained from the specific pathogen-free facility at the University of Aberdeen. Animal experiments were performed using age-matched female mice and conformed to the animal care and welfare protocols approved by the UK Home Office (project license 70/8073) in compliance with all relevant local ethical regulations. Clec1a −/− mice were generated commercially (TaconicArtemis) by conventional gene targeting in C57BL/6 embryonic stem cells, as detailed in Extended Data Fig. 7 . Sample sizes of at least five animals per group were chosen as this would allow the detection of a 25% difference in the mean between experimental and control groups with a probability of greater than 95% (P < 0.05), assuming a standard deviation of around 15% and a minimum power value of 0.8. Mice were randomly assigned to experimental or control groups, co-housed, and experiments were not blinded.
A. fumigatus isolate 13073 (American Type Culture Collection (ATCC)) and a clinical isolate CBS 144-89 (ref. 25) were used as wild-type strains. Melanin mutant strains (Δalb1(pksP1), Δayg1, Δabr1, Δabr2, Δarp1 and Δarp2 in the B5233 wild-type background) were generated previously 26 . ΔrodA and ΔpksPΔrodA deletion mutants were generated as described 9, 10, 25 . Wild-type CBS110. 46 (ref. 27) and CBS386.75 (ref. 27 ) strains with white conidia were also used, as indicated. All strains were maintained on 2% (w/v) malt-agar slants or potato dextrose agar in culture flasks; conidia were collected and washed before use. Swollen and/or germinating morphotypes were obtained upon incubating conidia in Sabouraud liquid culture medium at 37 °C for different time intervals, as indicated. Fc-MelLec production and immunolabelling. Soluble chimaeric proteins containing the stalk and C-type lectin-like domain of mouse and human MelLec fused to the mutated Fc portion of human immunoglobulin G1 (IgG1) were generated essentially as described previously 28 . In brief, the relevant portions of the MelLec encoding genes were amplified by PCR (mouse primers, GAATTCCTCGAGCTGGAGCTCTCCAGGTAC and AAGCTTTCTA CCAGCTGTCTAAT; human primers, GGGATCCACTACTACCAGCTCTCC and TGGATATCTGTCACCTTCGCCTAATGTTTC), and cloned into the pSecTag2 expression vector (Invitrogen Life Technologies) containing the mutated form of human IgG1 (ref. 29) . Sequenced constructs were transfected into HEK293T cells using Fugene 6 (Promega), as per the manufacturer's instructions. Fusion proteins were purified from conditioned supernatants by chromatography on protein A Sepharose and dialysed against PBS. Fc-Dectin-1 (ref. 28 ) and Fc-CLEC12B (ref. 24) were generated similarly and used as controls.
For flow cytometry, fungi were incubated in 1-3% (w/v) bovine serum albumin (BSA) in PBS and Fc-proteins were added to a final concentration of 5 μg ml −1 . Following incubation at 4 °C, fungal particles were washed in fluorescenceactivated cell sorting (FACS) buffer (0.5% (w/v) BSA and 2 mM EDTA in PBS), and bound Fc-proteins detected with allophycocyanin (APC) or phycoerythrin (PE)-conjugated donkey anti-human antibody (Jackson ImmunoResearch), fixed in 1% (v/v) formaldehyde, and analysed.
For microscopy, paraformaldehyde-fixed conidia were taken for immunolabelling 6 . To obtain NaOH-treated conidia, 1 M NaOH was added to conidia and heated in a boiling water bath for 1 h, followed by centrifugation to collect conidia and extensive washing. Melanin ghosts were isolated from conidia (B5233 as well as melanin mutant strains) by harsh chemical treatments that degrade other cellular components and result in hollow spherical-shaped melanin shells ('melanin ghosts'), as described previously 30 . For immunostaining, fungal particles were incubated with 5 μg ml −1 Fc-MelLec in PBS containing 1% (w/v) BSA for 1 h. After washing, bound Fc-MelLec was detected with fluorescein isothiocyanate (FITC)-labelled goat anti-human Fc-specific IgG (Sigma) in PBS containing 1% (w/v) BSA and washed with PBS-Tween. Conidia incubated with FITC-labelled anti-human Fc-specific IgG only were used as a negative control (data not shown). Labelled conidia were observed by fluorescence microscopy (Leica DMLB).
In some experiments, Fc-proteins were pretreated with either ghosts of melanin mutant strains, as indicated, or YWA1, which was isolated from AYG1 deletion mutant conidia as described previously 13 . Monoclonal antibody production. The generation of monoclonal antibodies to MelLec was performed essentially as described previously 31 . In brief, Sprague Dawley rats were immunized with Fc-MelLec in Freund's complete adjuvant. After a final intraperitoneal boost, without adjuvant, rat splenocytes were collected and fused with Y3 myeloma cells, as described 32 . Hybridoma supernatants were screened by ELISA and positives were then tested by immunohistochemistry and flow cytometry, as described below, against Fc-MelLec as well as MelLectransduced NIH3T3 fibroblasts. Two monoclonal antibodies (14C8 and 18E4; both IgG1) were selected for further use. Where required, they were biotinylated with Sulfo-NHS-LC Biotin (Pierce), as described by the manufacturer.
Cell culture and growth conditions. Cells were maintained at 37 °C and 5% CO 2 in DMEM or RPMI medium supplemented with 10% heat-inactivated fetal calf serum, 100 units per ml penicillin, 0.1 mg ml −1 streptomycin, and 2 mM l-glutamine. Phoenix ecotropic packaging cells (Plat-E) were maintained with the addition of 1 μg ml −1 puromycin and 10 μg ml −1 blasticidin (Life Technologies, Inc.).
NIH3T3 fibroblasts stably expressing full-length murine or human MelLec were generated essentially as described for Dectin-1 (ref. 33) . In brief, haemagglutinintagged MelLec was generated through PCR amplification (mouse primers, GGA TCCACCATGCAGGCCAAATACAGCA and CTCGAGCTACTGGAGCT CTCCAGGTAC; human primers, AAAGGATCCACCATGCAGGCCAAGT ACAGCAGCAC and AGCGTAATCCGGAACATCGTATGGGTACTCGAG) and subcloning into pFb-neo (Stratagene). Constructs were transfected into Plat-E retroviral packaging cell lines using Fugene 6 and retrovirus-containing supernatants were used to transduce NIH3T3 fibroblasts in the presence of polybrene (Sigma). Stably transfected cells were selected using 600 μg ml −1 G418 (ThermoFisher Inc.). The expression of the receptor was confirmed by flow cytometry and western blotting, using the anti-haemagglutinin antibody (Covance). In some experiments, NIH3T3 cells expressing murine CLEC12A (ref. 31) were used as controls. ELISA assays. Alkali-insoluble and soluble fungal cell wall fractions were obtained as described previously 34 . For the ELISA, wells were coated overnight with 20-200 μg ml −1 of the cell wall fractions, melanin ghosts (in-house generated), purified YWA1 (in-house generated), 1,8-DHN, 1,2-DHN, 1,4-DHN, naphthalene, 1-naphthol (all from Sigma) in 50 mM carbonate buffer pH 9.6, and then blocked with 1% BSA in PBS. Fc-MelLec (5 μg ml −1 ) was added to the wells and incubated for 1 h at room temperature. After washing with PBS-Tween-20 (0.5% (v/v)), peroxidase-conjugated human Fc-specific IgG (Sigma) was added to the wells and incubated for 1 h at room temperature. After further washing, quantification of Fc-MelLec binding was detected using o-phenylenediamine (Sigma) and H 2 O 2 detection system (Merck). The reaction was stopped using 4% (v/v) H 2 SO 4 and optical densities were measured at 492 nm. Expression analysis. Peripheral blood leucocytes, resident and thioglycolateelicited inflammatory peritoneal cells, alveolar macrophages and bone marrow cells were isolated essentially as described previously 35 . For platelets, peripheral blood was collected in 3.8% (w/v) sodium citrate buffer and centrifuged at 200g at 25 °C. The supernatant, containing platelet-rich plasma, was used for sub sequent analysis. Bone marrow-derived macrophages or dendritic cells, generated using L929 conditioned medium or 20 ng ml −1 granulocyte-macrophage colonystimulating factor (R&D Systems), respectively, were prepared as described 31 . In some experiments, cells were stimulated with 100 ng ml −1 lipopolysaccharide from Escherichia coli (Sigma).
Tissues isolated from mice were cut into small pieces and incubated for 30 min at 37 °C with Liberase (Roche) and DNase (Roche) in RPMI (Gibco), except for the small intestine which was incubated with Collagenase VIII (Sigma-Aldrich). Cells were disaggregated using the gentleMACS Dissociator (Miltenyi), strained through 70-μm nylon cell strainers (Fisher Scientific) and collected by centrifugation. Red blood cells were removed using Pharm Lyse (BD Biosciences).
For flow cytometry, isolated cells were washed in FACS wash (PBS with 0.5% (w/v) BSA and 5-10 mM EDTA) containing anti-CD16/CD32 (Clone 2.4G2, prepared in house). The following antibodies (all from BD Biosciences, eBioscience or Abcam) were used for FACS analysis of cell surface antigen expression following standard methodology: anti-MelLec-Biotin (described above), Streptavidin-PE-CF594 or Streptavidin-APC, anti-CD45.2-FITC (clone 104), biotinylated anti-CD61 (clone 2C9.G2), anti-CD326-APC (EpCAM; clone G8.8), anti-CD31-PE-Cyanine7 (PECAM-1; clone 390), anti-Ly6G-APC (clone 1A8), anti-CD11b-PE-Cy7 (clone M1/70), CD11c-PerCP-Cy5.5 (clone HL3), anti-Siglec-F-BV421 (clone E50-2440), anti-CD45-PE-Cy7 (clone 30-F11), anti-CD11b-PerCP-Cy5.5 (clone M1/70), anti-CD11c-BV421 (clone HL3), anti-Siglec-F-PE (clone E50-2440) and anti-F4/80-AF700 (clone CL:A3-1) and isotype control AFRC MAC 49 (ECACC 85060404; isotype for anti-MelLec). Cell viability was detected using the fixable viability dye eFluor-780 (eBioscience) in PBS, and the cells were fixed with 1% formaldehyde (v/v) before acquisition on a LSRII, LSR Fortessa or FACS Calibur (Becton Dickinson). Data were analysed using FlowJo. All contour plots were constructed using 2% probability contouring with outliers.
For immunofluorescence microscopy, 6 μm alcohol-fixed frozen lung sections were treated with Liberase (Roche) for 4 min at room temperature. Sections were blocked with 2% (v/v) normal goat serum, and incubated with anti-MelLec or isotype control for 1 h followed by AlexaFluor 488 goat anti-rat (Invitrogen) for 30 min. Vectashield with DAPI or propidium iodide (Vector Laboratories Inc.) was used as a mountant for fluorescence, and slides were visualized using a Zeiss LSM 700 confocal microscope. Visualization of transfected NIH3T3 cells was performed similarly, except the cells were fixed in 4% (v/v) paraformaldehyde before analysis.
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Detection of MelLec in complementary DNA (cDNA) (Multiple Tissue Panels, Clontech) was performed using the Titanium Taq PCR kit (Clontech) with the following primers: CAGAGCCCAGGCACTCAGAGAATG and TGCGGGAGAGCCCTGTCCAAT. Expression of G3PDH was detected as described previously 36 . Mouse infection models. For pulmonary infections, 10 5 (corticosteroid model) or 10 7 A. fumigatus ATCC 13073 conidia were administered to the caudal oropharynx of anaesthetized mice. In some experiments, mice were administered with 0.6 mg of the corticosteroid, triamcinolone acetonide 37 (Bristol-Myers Squibb), on days −1, 1 and 3, relative to infection on day 0. For systemic infections, 10 6 A. fumigatus ATCC 13073 conidia were administered to the lateral tail vein of mice. Mice were killed when they had lost 30% body weight or had become moribund. Pulmonary cellular inflammation was assessed by flow cytometry after total lung enzymatic digest, as described above, or in bronchoalveolar lavage samples, isolated with PBS containing 5 mM EDTA (Gibco). Organs were homogenized in PBS and used for the determination of fungal burdens and levels of inflammatory cytokines. Fungal burdens were determined by serial dilution onto potato dextrose agar plates and normalized to organ weights. Cytokines were measured by ELISA (R&D DuoSet), as described by the manufacturer, and normalized to protein concentration. Bone marrow chimaeric mice were generated as described previously 38 . Glycan microarray analyses. Microarray analyses were carried out using the neoglycolipid-based microarray system 39 . Details of the glycan probe library, the generation of the microarrays, imaging and data analysis are in the supplementary glycan microarray document ( Supplementary Table 3 ) in accordance with the MIRAGE (minimum information required for a glycomics experiment) guidelines for reporting glycan microarray-based data. The microarray contained 496 lipidlinked glycan probes (Supplementary Table 1 ). Microarray analysis of the soluble Fc-MelLec was performed essentially as described 8 . In brief, after blocking arrayed slides with 0.04% (v/v) Blocker Casein (Pierce), 1% (w/v) BSA (Sigma A8577) in HEPES-buffered saline (5 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM CaCl 2 ), mouse Fc-MelLec was precomplexed with biotinylated anti-human IgG (Vector) at a 1:3 ratio (w/w) before application onto the slides at a final concentration of 10 μg ml −1 . Flag-tagged human langerin was included as a positive control. The protein and rat anti-Flag antibody mAb L5 were provided by C. G. Park. For analysis, the Flag-tagged langerin was precomplexed with the rat anti-Flag at a 1:3 ratio (w/w) and applied onto the slides at a final concentration of 5 μg ml −1 , followed by biotinylated anti-rat IgG (Pierce) (5 μg ml −1 ). To detect binding, AlexaFluor-647labelled streptavidin from Molecular Probes was used at 1 μg ml −1 . Data analysis and presentation was performed with dedicated glycan microarray software 40 . Human studies. A total of 310 haematologic patients undergoing allogeneic haematopoietic stem cell transplantation at the Hospital of Santa Maria, Lisbon and Instituto Português de Oncologia (IPO), Porto, between 2009 and 2014 were enrolled in the study. The cases of invasive aspergillosis were identified and classified as 'probable' or 'proven' according to the revised standard criteria from the European Organization for Research and Treatment of Cancer/Mycology Study Group (EORTC/MSG) 41 . Exclusion criteria included diagnosis of 'possible' invasive aspergillosis, infection with invasive moulds other than Aspergillus spp. or history of pre-transplant mould infection. Study approval was obtained from the institutional review boards (SECVS-125/2014, HSM-632/14 and CES.26/015) and from the National Data Protection Commission (CNPD, 1950 (CNPD, /2015 and was in compliance with all local relevant ethical regulations.
Genomic DNA was isolated from whole blood of recipients and donors (before transplantation) using the QIAcube automated system (Qiagen) at the regional centres of the Instituto Português do Sangue e Transplantação (Portugal). Genotyping of the nonsynonymous rs2306894 SNP in the CLEC1A gene was performed using KASPar assays (LGC Genomics) according to the manufacturer's instructions in an Applied Biosystems 7500 Fast real-time PCR system (Thermo Fisher). Genotyping sets included randomly selected replicates of previously typed samples, and agreement between original and duplicate samples was ≥ 99%.
Peripheral blood mononuclear cells from healthy genotyped donors were enriched from buffy coats using Histopaque-1077 (Sigma-Aldrich) and contaminating erythrocytes were removed using Red Blood Cell Lysis Buffer (Sigma-Aldrich). Participants gave written informed consent before blood collection. Monocytes were isolated by positive selection using magnetically labelled CD14 + MicroBeads (Miltenyi Biotec) on a MiniMACS separator and seeded at 10 6 cells per ml in 24-well plates for 7 days in RPMI-1640 medium supplemented with 10% (v/v) human serum and 20 ng ml −1 recombinant human granulocyte macrophage colony-stimulating factor (GM-CSF, Gibco). Acquisition of macrophage morphology was confirmed by phase contrast microscopy (Axiovert 135, Zeiss). For infection, macrophages were washed and then infected with live conidia of A. fumigatus strain A1163 at a ratio of 1:10 (cells:fungus) for 20 h at 37 °C and 5% CO 2 . Cytokines in supernatants were detected using DuoSet ELISA systems (BioLegend), according to the manufacturer's instructions. At least two technical replicates were performed for each donor.
For the independent cohort, genomic DNA was isolated from EDTA venous blood of healthy Dutch volunteers using the Gentra Pure Gene Blood kit (Qiagen) and genotyped for CLEC1A polymorphisms using the Illumina Immunochip SNP array platform, described previously 42 . Participants gave written informed consent before blood collection. As the CLEC1A SNP of interest (exonic rs2306894) was not represented on the genotyping platform, two intronic polymorphisms (rs7972187 and rs3825300) were used as markers. Linkage analysis revealed complete linkage disequilibrium of these two polymorphisms with the SNP of interest 43 (R 2 = 1). A total of 10 5 peripheral blood mononuclear cells isolated from genotyped donors were stimulated with 10 7 killed conidia per ml of the clinical isolate A. fumigatus V05-27 (ref. 44) . After 24-h incubation in the presence of 10% human pooled serum at 37 °C and 5% CO 2 , supernatants were collected and IL-1β and IL-8 were measured by ELISA (R&D Systems and PeliKine, respectively). Statistical analysis. The probability of invasive aspergillosis resulting from CLEC1A rs2306894 SNP was analysed using the cumulative incidence method and compared using Gray's test 45 . Cumulative incidences were computed with the cmprsk package for R version 2.10.1 (ref. 46) , with censoring of data at the date of last follow-up visit and defining relapse and death as competing events. A period of 24 months after transplant was chosen to include all cases of fungal infection. Mouse survival data were analysed with the log rank test using GraphPad Prism. No data was excluded.
In vitro and ex vivo data were analysed using the GraphPad Prism software. Two-tailed student's t-tests or Mann-Whitney U tests were used to determine statistical significance. All experiments were independently repeated at least once, unless otherwise indicated. Data availability. The data that support the findings of this study are available from the corresponding author upon reasonable request. Supplementary Fig. 1 ). d, Relative binding of FITC-labelled ΔrodA A. fumigatus conidia to NIH3T3 cells transduced with vector only, Dectin-1 or MelLec, as determined by flow cytometry. Values shown are mean ± s.d., analysed by one-way ANOVA. e, Screening of hybridoma supernatants on MelLec-expressing (red) and parental (black) NIH3T3 cells. In b-e, experiments were repeated at least three times independently, with similar results. *P ≤ 0.05; NS, not significant.
Extended Data Figure 7 | MelLec expression in tissues and generation of Clec1a −/− mice. a, Immunofluorescence microscopy of MelLecexpressing versus control NIH3T3 cells labelled with anti-MelLec antibody (green). Nuclei are stained with DAPI (blue). Experiments were repeated at least three times independently, with similar results. b, Exemplar flowcytometric gating strategy for identification of live cells from tissue. c, Flow-cytometric analysis of MelLec expression on live CD45 − CD31 + EpCAM − and EpCAM + populations in the liver. d-j, Flow cytometric analysis of MelLec expression on live CD45 − CD31 + cells in the heart (d), kidney (e) and small intestine (f), and on live CD45 − EpCAM + cells in the heart (g), kidney (h), small intestine (i) and epidermis (j). In b-j, experiments were repeated at least twice independently, with similar results. Black lines, isotype controls. k, Schematic of the wild-type Clec1a locus, gene targeting vector, PCR primer sites and correctly targeted recombinant allele. l, PCR analysis of gene-targeted mice (for gel source data, see Supplementary Fig. 1 ). +/+, wild-type, +/− heterozygous and −/− homozygous for the targeted allele. m, Immunofluorescence microscopy of naive lung tissue from Clec1a −/− mice (labelling of wild-type lung is shown in Fig. 3b ). n, Analysis of MelLec expression in disaggregated lung tissue from wild-type (wt) or Clec1a −/− mice by flow cytometry. In l-n, experiments were repeated at least three times independently, with similar results. h, Cellular inflammatory profiles of mice 24 h after challenge with 10 7 A. fumigatus conidia (wild-type n = 33 mice, Clec1a −/− n = 30 mice). Alveolar macrophages were defined as CD11c + Siglec-F + , inflammatory macrophages as CD11b + F4/80 + and eosinophils as CD11b + Siglec-F + . In d-h, values shown are mean ± s.e.m. of pooled data from at least two independent experiments, analysed by two-sided Mann-Whitney U test. i, Expression of MelLec on pulmonary CD45 − CD31 + cells isolated from uninfected mice (black) and mice 24 h after infection with A. fumigatus conidia (red). Grey line, isotype control (n = 3 mice per group). j, Pulmonary CD11b + Ly6G high neutrophils in mice 4 h after challenge with 10 7 ΔpksP A. fumigatus conidia (wild-type n = 7 mice, Clec1a −/− n = 8 mice). Values shown are mean ± s.e.m. of pooled data from two independent experiments, analysed by two-sided Mann-Whitney U test. k, Representative FACS profiles of pulmonary CD11b + Ly6G high neutrophils in wild-type and Clec1a −/− mice 4 h after challenge with 10 7 ΔpksP A. fumigatus conidia (wild-type n = 7 mice, Clec1a −/− n = 8 mice). *P ≤ 0.05; NS, not significant. Sample sizes of at least five per group were chosen as this would allow the detection of a 25% difference in the mean between experimental and control groups with a probability of greater than 95% (p < 0.05), assuming a standard deviation of around 15% and a minimum power value of 0.8.
Data exclusions
Describe any data exclusions. There were no data exclusions except for data shown in Extended figure 10c, where samples with blood contamination were excluded. This is indicated in the manuscript.
Replication
Describe whether the experimental findings were reliably reproduced.
All experiments were independently replicated at least once.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice were randomly assigned to experimental or control groups, co-housed, and experiments were not blinded.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company. c. Report whether the cell lines were tested for mycoplasma contamination.
Mycoplasma tests were done historically on these cell lines, but not for the experiments detailed in the manuscript. Genomic DNA was isolated from whole blood of recipients and donors (before transplantation) using the QIAcube automated system (Qiagen) at the regional centres of the Instituto Português do Sangue e Transplantação (Portugal). Genotyping of the nonsynonymous rs2306894 SNP in the CLEC1A gene was performed using KASPar assays (LGC Genomics) according to manufacturer's instructions in an Applied Biosystems 7500 Fast real-time PCR system (Thermo Fisher). Genotyping sets included randomly selected replicates of previously typed samples, and agreement between original and duplicate samples was ≥99%.
Peripheral blood mononuclear cells from healthy genotyped donors were enriched from buffy coats using Histopaque®-1077 (Sigma-Aldrich) and contaminating erythrocytes removed using Red Blood Cell Lysis Buffer (Sigma-Aldrich). Participants gave written informed consent prior to blood collection. Monocytes were isolated by positive selection using magnetically labelled CD14+ MicroBeads (Miltenyi Biotec) on a MiniMACS separator and seeded at 106 cells/mL in 24-well plates for 7 days in RPMI-1640 medium supplemented with 10% (v/v) human serum and 20 ng/mL recombinant human granulocyte macrophage colonystimulating factor (GM-CSF, Gibco). Acquisition of macrophage morphology was confirmed by phase contrast microscopy (Axiovert 135, Zeiss). For infection, macrophages were washed and then infected with live conidia of A. fumigatus strain A1163 at a ratio of 1:10 (cells/fungus) for 20 h at 37°C and 5% CO2. Cytokines in supernatants were detected using DuoSet ELISA systems (BioLegend), according to the manufacturer's instructions. At least two technical replicates were performed for each donor. For the independent cohort, genomic DNA was isolated from EDTA venous blood of healthy Dutch volunteers using the Gentra Pure Gene Blood kit (Qiagen, Venlo, The Netherlands) and genotyped for CLEC1A polymorphisms using the Illumina Immunochip SNP array platform, described previously42. Participants gave written informed consent prior to blood collection. As the CLEC1A SNP of interest (exonic rs2306894) was not represented on the genotyping platform, two intronic polymorphisms (rs7972187 and rs3825300) were used as markers. Linkage analysis revealed complete linkage disequilibrium of these two polymorphisms with the SNP of interest43 (R2=1). 105 PBMCs isolated from genotyped donors were stimulated with 107 killed conidia/mL of the clinical isolate A. fumigatus V05-2744. After 24 h incubation in the presence of 10% human pooled serum at 37°C and 5% CO2 supernatants were collected and IL-1β and IL-8 were measured by ELISA (R&D Systems, UK, and PeliKine, Sanquin, The Netherlands, respectively). The probability of invasive aspergillosis resulting from CLEC1A rs2306894 SNP was analysed using the cumulative incidence method and compared using Gray's test45. Cumulative incidences were computed with the cmprsk package for R version 2.10.146, with censoring of data at the date of last follow-up visit and defining relapse and death as competing events. A period of 24 months after transplant was chosen to include all cases of fungal infection. Murine survival data were analysed with the log rank test using GraphPad Prism. No data was excluded.
